Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0125 | 0.0359 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0083 | 0.0015 | 1 |
Schistosoma mansoni | family A2 unassigned peptidase (A02 family) | 0.0237 | 0.1272 | 0.1272 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0081 | 0 | 0.5 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0081 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin I | 0.0081 | 0 | 0.5 |
Plasmodium vivax | plasmepsin IV, putative | 0.0081 | 0 | 0.5 |
Plasmodium falciparum | plasmepsin II | 0.0081 | 0 | 0.5 |
Brugia malayi | Matrixin family protein | 0.0083 | 0.0015 | 0.5 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0082 | 0.0003 | 0.0003 |
Plasmodium falciparum | plasmepsin IV | 0.0081 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | extracellular metallopeptidase | 0.0902 | 0.6725 | 0.5 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0174 | 0.0761 | 0.0761 |
Plasmodium falciparum | plasmepsin VI | 0.0081 | 0 | 0.5 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0081 | 0 | 0.5 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0174 | 0.0761 | 0.0761 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0449 | 0.3011 | 0.3011 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0125 | 0.0359 | 1 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0081 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Delta Tm (binding) | = 1 degrees C | Binding affinity to castor seed ricin A chain in rabbit reticulocyte lysate assessed as change in melting temperature at 500 uM after 30 mins by differential scanning calorimetry | ChEMBL. | 21641093 |
IC50 (binding) | = 500 uM | Inhibition of castor seed ricin A chain translation degradation activity in rabbit reticulocyte lysate after 90 mins by luciferase-based luminometer analysis | ChEMBL. | 21641093 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.